301 related articles for article (PubMed ID: 29572377)
1. Preclinical evaluation of
Nishii R; Moriyama T; Janke LJ; Yang W; Suiter CC; Lin TN; Li L; Kihira K; Toyoda H; Hofmann U; Schwab M; Takagi M; Morio T; Manabe A; Kham S; Jiang N; Rabin KR; Kato M; Koh K; Yeoh AE; Hori H; Yang JJ
Blood; 2018 May; 131(22):2466-2474. PubMed ID: 29572377
[TBL] [Abstract][Full Text] [Related]
2. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia.
Moriyama T; Nishii R; Lin TN; Kihira K; Toyoda H; Jacob N; Kato M; Koh K; Inaba H; Manabe A; Schmiegelow K; Yang JJ; Hori H
Pharmacogenet Genomics; 2017 Jun; 27(6):236-239. PubMed ID: 28445187
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations.
Maillard M; Nishii R; Yang W; Hoshitsuki K; Chepyala D; Lee SHR; Nguyen JQ; Relling MV; Crews KR; Leggas M; Singh M; Suang JLY; Yeoh AEJ; Jeha S; Inaba H; Pui CH; Karol SE; Trehan A; Bhatia P; Antillon Klussmann FG; Bhojwani D; Haidar CE; Yang JJ
J Natl Cancer Inst; 2024 May; 116(5):702-710. PubMed ID: 38230823
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine-mediated impairment of hematopoietic stem and leukemia cells in Nudt15
Tatsumi G; Kawahara M; Imai T; Nishishita-Asai A; Nishida A; Inatomi O; Yokoyama A; Kakuta Y; Kito K; Andoh A
Leukemia; 2020 Mar; 34(3):882-894. PubMed ID: 31645647
[TBL] [Abstract][Full Text] [Related]
5. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.
Zgheib NK; Akika R; Mahfouz R; Aridi CA; Ghanem KM; Saab R; Abboud MR; Tarek N; El Solh H; Muwakkit SA
Pediatr Blood Cancer; 2017 Jan; 64(1):146-150. PubMed ID: 27577869
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility to 6-mercaptopurine toxicity related with NUDT15 and ABCC4 variants in Japanese childhood acute lymphoblastic leukemia].
Tanaka Y
Rinsho Ketsueki; 2017; 58(8):950-956. PubMed ID: 28883280
[TBL] [Abstract][Full Text] [Related]
7. Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
Zhou H; Li L; Yang P; Yang L; Zheng JE; Zhou Y; Han Y
BMC Cancer; 2018 May; 18(1):516. PubMed ID: 29720126
[TBL] [Abstract][Full Text] [Related]
8. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.
Yang JJ; Landier W; Yang W; Liu C; Hageman L; Cheng C; Pei D; Chen Y; Crews KR; Kornegay N; Wong FL; Evans WE; Pui CH; Bhatia S; Relling MV
J Clin Oncol; 2015 Apr; 33(11):1235-42. PubMed ID: 25624441
[TBL] [Abstract][Full Text] [Related]
9. Effect of NUDT15 on incidence of neutropenia in children with acute lymphoblastic leukemia.
Buaboonnam J; Sripatanatadasakul P; Treesucon A; Glomglao W; Siraprapapat P; Narkbunnam N; Vathana N; Takpradit C; Phuakpet K; Pongtanakul B; Tongsai S; Sinlapamongkolkul P; Sanpakit K
Pediatr Int; 2019 Aug; 61(8):754-758. PubMed ID: 31166660
[TBL] [Abstract][Full Text] [Related]
10.
Fan POL; Leung KT; Chan KYY; Leung AWK; Lam GKS; Chow TTW; Cheng FWT; Yuen LYP; Moriyama T; Yang JJ; Li CK
Pediatr Hematol Oncol; 2022 Apr; 39(3):254-266. PubMed ID: 34665987
[TBL] [Abstract][Full Text] [Related]
11. The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia.
Wahlund M; Nilsson A; Kahlin AZ; Broliden K; Myrberg IH; Appell ML; Berggren A
J Pediatr; 2020 Jan; 216():150-157.e1. PubMed ID: 31635813
[TBL] [Abstract][Full Text] [Related]
12. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.
Moriyama T; Nishii R; Perez-Andreu V; Yang W; Klussmann FA; Zhao X; Lin TN; Hoshitsuki K; Nersting J; Kihira K; Hofmann U; Komada Y; Kato M; McCorkle R; Li L; Koh K; Najera CR; Kham SK; Isobe T; Chen Z; Chiew EK; Bhojwani D; Jeffries C; Lu Y; Schwab M; Inaba H; Pui CH; Relling MV; Manabe A; Hori H; Schmiegelow K; Yeoh AE; Evans WE; Yang JJ
Nat Genet; 2016 Apr; 48(4):367-73. PubMed ID: 26878724
[TBL] [Abstract][Full Text] [Related]
13. Massively parallel variant characterization identifies
Suiter CC; Moriyama T; Matreyek KA; Yang W; Scaletti ER; Nishii R; Yang W; Hoshitsuki K; Singh M; Trehan A; Parish C; Smith C; Li L; Bhojwani D; Yuen LYP; Li CK; Li CH; Yang YL; Walker GJ; Goodhand JR; Kennedy NA; Klussmann FA; Bhatia S; Relling MV; Kato M; Hori H; Bhatia P; Ahmad T; Yeoh AEJ; Stenmark P; Fowler DM; Yang JJ
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5394-5401. PubMed ID: 32094176
[TBL] [Abstract][Full Text] [Related]
14. Novel variants in
Moriyama T; Yang YL; Nishii R; Ariffin H; Liu C; Lin TN; Yang W; Lin DT; Yu CH; Kham S; Pui CH; Evans WE; Jeha S; Relling MV; Yeoh AE; Yang JJ
Blood; 2017 Sep; 130(10):1209-1212. PubMed ID: 28659275
[TBL] [Abstract][Full Text] [Related]
15. [Significance of NUDT15 gene in individualized treatment with 6-mercaptopurine in children with acute lymphoblastic leukemia].
He J; Liu L
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jan; 21(1):100-104. PubMed ID: 30675872
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping.
Kakuta Y; Kinouchi Y; Shimosegawa T
J Gastroenterol; 2018 Feb; 53(2):172-180. PubMed ID: 29192347
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic evaluation of 6-mercaptopurine-mediated toxicity in pediatric acute lymphoblastic leukemia patients from a South Indian population.
Ramalingam R; Kaur H; Scott JX; Sneha LM; Arun Kumar GP; Srinivasan A; Paul SF
Pharmacogenomics; 2021 May; 22(7):401-411. PubMed ID: 33876659
[No Abstract] [Full Text] [Related]
18. NUDT15 genetic testing-guided 6-mercaptopurine dosing in children with ALL likely to be cost-saving in China.
Wei X; Zhuang J; Li N; Zheng B; Sun H; Cai J; Huang X; Zhang G; Zhuang J
Int J Hematol; 2022 Feb; 115(2):278-286. PubMed ID: 34709580
[TBL] [Abstract][Full Text] [Related]
19. NUDT15 Variants Cause Hematopoietic Toxicity with Low 6-TGN Levels in Children with Acute Lymphoblastic Leukemia.
Yi ES; Choi YB; Choi R; Lee NH; Lee JW; Yoo KH; Sung KW; Lee SY; Koo HH
Cancer Res Treat; 2018 Jul; 50(3):872-882. PubMed ID: 28903549
[TBL] [Abstract][Full Text] [Related]
20. Genotyping NUDT15 can predict the dose reduction of 6-MP for children with acute lymphoblastic leukemia especially at a preschool age.
Suzuki H; Fukushima H; Suzuki R; Hosaka S; Yamaki Y; Kobayashi C; Sakai A; Imagawa K; Iwabuchi A; Yoshimi A; Nakao T; Kato K; Tsuchida M; Kiyokawa N; Koike K; Noguchi E; Fukushima T; Sumazaki R
J Hum Genet; 2016 Sep; 61(9):797-801. PubMed ID: 27193222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
